Resistant Enterobacteriaceae : the explosion of extended-spectrum β-lactamases (ESBL);Entérobactéries résistantes : Explosion des β-lactamases à spectre élargi

Revue Medicale Suisse

Volumn 8, Issue 357, 2012, Pages 1925-1929

  Berthod, D ^a   Pouget, R ^c   San Millan D ^b   Troillet, N ^a  

^a Service des Maladies Infectieuses   (Switzerland)

^b Hopital du Valais   (Switzerland)

^c Hopital du Valais   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CASE REPORT; ENTEROBACTERIACEAE; ENZYME ACTIVITY; HUMAN; INFECTION PREVENTION; NONHUMAN; PREVALENCE; REVIEW;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 84868254285     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Bhullar K, Waglechner N, Pawlowski A, et al. Antibiotic resistance is prevalent in an isolated cave microbiome. PLoS One 2012;7:e34953.
2. D'Costa VM, King CE, Kalan L, et al. Antibiotic resistance is ancient. Nature 2011;477:457-61.
3. Livermore DM. Resistance in Gram-negative bacteria. Korean J Intern Med 2012;27:128-42.
4. Centre suisse pour le contrôle de l'antibiorésistance. Données de résistance, médecine humaine. www.anresis.ch
5. Filippini M, Gonzalez Ortiz LG, Masiero G. Assessing the impact of national antibiotic campaigns in Europe. Eur J Health Econ 2012; epub ahead of print.
6. Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients : Systematic review and meta-analysis. BMJ 2010;340:c2096.
7. Kuster SP, Hasse B, Huebner V, et al. Risks factors for infections with extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection 2010;38:33-40.
8. Van der Bij AK, Pitout JD. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 2012;67: 2090-100.
9. Tängden T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonisation with Escherichia coli producing CTX-M-type extended-spectrum b-lactamases : A prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010;54: 3564-8.
10. Kennedy K, Collignon P. Colonisation with Escherichia coli resistant to «critically important» antibiotics : A high risk for international travellers. Eur J Clin Microbiol Infect Dis 2010;29:1501-6.
11. Patel U, Dasgupta P, Amoroso P, et al. Infection after transrectal ultrasonography-guided prostate biopsy : Increased relative risk after recent international travel or antibiotic use. BJU Int 2012;109:1781-5.
12. Hilty M, Betsch B, Bögli-Stuber K, et al. Transmission dynamics of extended-spectrum b-lactamase (ESBL)- producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis 2012; 55:967-75.
13. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, et al. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011;17:873-80.
14. Achermann R, Suter K, Kronenberg A, et al. Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests. Clin Microbiol Infect 2011;17:855-61.
15. Schuetz P, Amin DN, Greenwald JL. Role of procalcitonin in managing adult patients with respiratory tract infections. Chest 2012;141:1063-73.
16. Chabok A, Pahlman L, Hjern F, et al. Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg 2012;99:532-9.
17. Schrag SJ, Pena C, Fernandez J, et al. Effect of short-course, high dose amoxicillin therapy on resistant pneumococcal carriage. A randomized trial. JAMA 2001; 286:49-56.
18. Duc Volluz S, Abbet P, Troillet N. Quelle est la durée optimale de l'antibiothérapie pour les infections fréquentes ? Rev Med Suisse 2010;6:1901-5.
19. Taylor AK, Zembower TR, Nadler RB, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 2012;187:1275-9.
20. Abbas M, Cherkaoui A, Fankhauser C, Schrenzel J, Harbarth S. Carbapénémases : implications cliniques et épidé miologiques pour la Suisse. Rev Med Suisse 2012; 8:882-9.